SCHEMBL13299178

SCHEMBL13299178

COCCOCCOCCOCCOC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 3/20 0.65
CYP2C9 P11712 2/20 0.65
USP2 O75604 1/20 0.65
LMNA P02545 1/20 0.65
TBXA2R P21731 1/20 0.65
MAPK1 P28482 1/20 0.65
KMT2A Q03164 1/20 0.65
PTGS2 P35354 6/20 0.57
PTGS1 P23219 2/20 0.57
AKR1B10 O60218 1/20 0.57
UGT1A9 O60656 1/20 0.57
TRPA1 O75762 1/20 0.57
ABCB11 O95342 1/20 0.57
MT-CO2 P00403 1/20 0.57
ALB P02768 1/20 0.57
CXCL8 P10145 1/20 0.57
UGT1A6 P19224 1/20 0.57
UGT1A1 P22309 1/20 0.57
CXCR1 P25024 1/20 0.57
ADRA1A P35348 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10310898 1.00 TTR (0.65) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL13777335 1.00 TTR (0.65) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL30697979 0.92 TTR (0.59) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL26770322 0.92 TTR (0.59) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL13109328 0.91 TTR (0.65) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL13777334 0.89 TTR (0.67) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL14605848 0.89 TTR (0.67) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL6950571 0.89 TTR (0.67) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL13800457 0.89 TTR (0.67) TTRCYP2C9USP2LMNATBXA2R
SCHEMBL13299158 0.88 TTR (0.65) TTRCYP2C9USP2LMNATBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9403756-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2016-08-02 US disclosed
US-9403756-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2016-08-02 US disclosed
US-20140316008-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-10-23 US disclosed
US-20140316008-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-10-23 US disclosed
US-8765815-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-07-01 US disclosed
US-8765815-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-07-01 US disclosed
US-20100137296-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2010-06-03 US disclosed
US-20100137296-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137296-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF TRPV1, TRPA1, TRPV4 TTR 4167/4885CYP2C9 4025/4885USP2 4465/4885
US-20140316008-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF TRPV1, TRPA1, TRPV4 TTR 4167/4885CYP2C9 4025/4885USP2 4465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.